Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistITL Asia Pacific Sdn Bhd, a medical device manufacturer, received an FDA Warning Letter on September 25, 2019, indicating regulatory compliance concerns with their operations or products. Based on the available metadata, the specific violations cannot be detailed as the subject line and full letter contents are not provided. The warning relates to medical device regulation, though the specific issuing FDA office and exact nature of the violations remain unclear from the metadata alone. To understand the full scope of the regulatory action, the complete Warning Letter would need to be reviewed.